Business

Philips braces for €250 mil hit due to product safety risk

Dutch firm says issue concerns sound-dampening foam in some sleep, respiratory care devices

Updated 5 years ago · Published on 26 Apr 2021 9:30PM

Philips braces for €250 mil hit due to product safety risk
The Amsterdam-based Philips started off as a lighting company more than 100 years ago, but has undergone major changes in recent years, focusing in particular on remote healthcare. – EPA pic, April 26, 2021

THE HAGUE – Dutch firm Philips today said it anticipates a hit of up to €250 million (RM1.2 billion) from a possible safety risk in some sleep and respiratory care products, even as first-quarter profits edged higher.

The company, which has diversified into healthcare and last month sold off its domestic appliance business, said net profit was €40 million in the three months to March 31, a 2.6% rise on a year earlier.

Philips had sales of €3.8 billion in Q1, up 3.6% from the same period last year.

“Regretfully, we have identified a quality issue in a component that is used in certain sleep and respiratory care products, and are initiating all precautionary actions to address this issue, for which we have taken a €250 million provision,” said CEO Frans van Houten in a statement.

Philips said there are “possible risks to users” from sound-dampening foam in some sleep and respiratory care devices, which could degrade under conditions including unapproved cleaning methods, plus high humidity and temperature. 

The firm said it is talking to regulators about the problem, which mainly affects first-generation DreamStation products, and “initiating appropriate actions to mitigate these possible risks”.

The Amsterdam-based company started off as a lighting firm more than 100 years ago, but has undergone major changes in recent years, focusing in particular on remote healthcare.

Philips announced last month that it is selling its home appliance business to Asian investment firm Hillhouse Capital for €3.7 billion, and sales from this are now listed under discontinued operations, according to today’s results statement.

The firm said despite continued “uncertainty” related to the Covid-19 pandemic, it has upgraded its sales forecast for 2021 on the back of increased demand for its healthcare products. – AFP, April 26, 2021

Related News

Malaysia / 1y

Gua Kepah prehistoric skeletal remains expected back in Penang by year end

Malaysia / 1y

Netherlands water management experts to help Sarawak with flooding and supply issues

Malaysia / 1y

Netherlands offers to help Sarawak in flood prevention

World / 3y

Dutch expel Russian diplomats, close trade mission

Our Planet / 3y

Dutch flood memories unleash new climate fears

World / 3y

Quran burning: Al-Azhar Uni calls for Swedish, Danish goods boycott

Spotlight

Anwar unveils six measures for Malaysians ahead of Merdeka

By Alfian Z.M. Tahir

Malaysia

Xavier Jayakumar warns racial, religious politics could erode Malaysia’s unity

Malaysia

DOE: Close schools, kindergartens if API tops 200

Malaysia

WhatsApp messages help rescue of two brothers lost in Bukit Putus

Malaysia

King grants audience to Anwar, briefed on Merdeka Day preparations

Opinion

Merdeka: This is our Malaysia – and you will not take it from us

By Vinod Sekhar

World

Covid-19 fears return in South Korea as mask, test kit sales surge

World

91 Malaysians still unaccounted for after Nepal-China floods

You may be interested

Business

Oil prices fall as Hormuz reopening hopes offset Iran tensions

Business

Property developer, Matrix Concepts sets RM1.8b FY2027 sales target

Business

Robo.ai swings to positive equity after US$46.7m first-half profit

By Alfian Z.M. Tahir